JBS: Meat In The U.S. Has Never Been So Expensive, And This Company Can Help Pay The Bill Summary - I reiterate my buy recommendation on JBS, citing strong upside potential and resilient fundamentals. - JBS maintains best-in-class financials and global diversification, yet trades at a significant valuation discount to peers. - Despite a recent NYSE listing, JBS's valuation has not converged with competitors, offering a 22% upside if multiples normalize. - Emerging US legislative risk around meatpacker market concentration is notable but does not alter my positive outlook at this stage. Analyst

JBS: Meat In The U.S. Has Never Been So Expensive, And This Company Can Help Pay The Bill Summary - I reiterate my buy recommendation on JBS, citing strong upside potential and resilient fundamentals. - JBS maintains best-in-class financials and global diversification, yet trades at a significant valuation discount to peers. - Despite a recent NYSE listing, JBS's valuation has not converged with competitors, offering a 22% upside if multiples normalize. - Emerging US legislative risk around meatpacker market concentration is notable but does not alter my positive outlook at this stage. Analyst